Back

Effect of severe tricuspid regurgitation on the prognosis of patients with atrial functional mitral regurgitation: the REVEAL-AFMR registry

1 September 2024 (09:00 - 09:30)
Organised by: Logo
Congress Presentation Part of: Advancing knowledge in valvular heart disease: the role of registries Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Tomohiro Kaneko

Juntendo University Graduate School of Medicine, Tokyo (Japan)

4 More presentations in this session

Presentation thumbnail
Overview of the risk of myocardial infarction in patients with aortic stenosis: insights from the VALVENOR Registry.
Professor G. Lemesle (Lille, FR)
Abstract Slides Video
Presentation thumbnail
Incidence, predictors and outcomes of non-home discharge following transcatheter aortic valve implantation: a multicentre Australian experience. The NHD TAVI study.
Doctor A. Butala (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Gender-specific differences in severe tricuspid regurgitation. Finding from a TR multicentre CMR registry
Doctor S. Rodriguez Diego (Salamanca, ES)
Abstract Slides Video
Presentation thumbnail
Natural progression of rheumatic aortic valve disease following rheumatic mitral valve intervention: 16-year single center experience
Assistant Professor S. Kim (Yangsan, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Advancing knowledge in valvular heart disease: the role of registries

The Event

Event poster

ESC Congress 2024

1 September 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Tricuspid regurgitation in the context of severe concomitant left-sided valvular heart disease: patients characteristics and long-term clinical and interventional outcomes
thumbnail
Congress Presentation
Atrial functional tricuspid regurgitation in patients undergoing transcatheter aortic valve replacement
thumbnail
Congress Presentation
Impact of atrial fibrillation on progression of tricuspid regurgitation in patients undergoing transcatheter aortic valve replacement

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources